Data from Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association
Hilde Brems(Center for Human Genetics), Douglas R. Stewart(Cancer Genetics (United States)), Ludwine Messiaen(University of Alabama at Birmingham), Kristel Peeters, Kathleen Claes(Statistics Belgium), Meena Upadhyaya(Cardiff University), Caroline Park, Jennifer L. Sloan(National Institutes of Health), Eric Legius(Center for Human Genetics), Luc De Smet(KU Leuven), Eline Beert, Raf Sciot(KU Leuven), Ophélia Maertens(American Institutes for Research), Victor Mautner(Universität Hamburg), Chyi‐Chia Richard Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Lawrence Yao(Center for Clinical Research (United States)), Alexander Pemov
Cited by 0
Related Papers
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766